Role of CMV in immune senescence
- PMID: 20869407
- DOI: 10.1016/j.virusres.2010.09.010
Role of CMV in immune senescence
Abstract
"Immune senescence" is a descriptive term for the deleterious age-associated changes to immunity observed in all mammals studied so far. While all components of innate and adaptive immunity are changed with age, the clinical impact of these changes is not clear, and mechanisms of and markers for immunosenescence are controversial. In humans, several cross-sectional studies have demonstrated that the major accepted age-associated changes to parameters used to assess adaptive immune status are markedly influenced by infection with cytomegalovirus (CMV). In the very limited longitudinal studies thus far carried out, a cluster of immune parameters associating with 2-, 4- and 6-year survival of the very elderly has been identified and termed the "immune risk profile" (IRP). This cluster includes seropositivity for CMV and is characterised by accumulations of clonal expansions of late-differentiated CD8+ T cells, many of which are specific for CMV antigens. Here we review the impact of CMV on "immune senescence" in humans.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Cytomegalovirus and human immunosenescence.Rev Med Virol. 2009 Jan;19(1):47-56. doi: 10.1002/rmv.598. Rev Med Virol. 2009. PMID: 19035529 Review.
-
Immunosenenescence: role of cytomegalovirus.Exp Gerontol. 2014 Jun;54:1-5. doi: 10.1016/j.exger.2013.11.010. Epub 2013 Nov 28. Exp Gerontol. 2014. PMID: 24291068 Review.
-
Human cytomegalovirus infection and T cell immunosenescence: a mini review.Mech Ageing Dev. 2006 Jun;127(6):538-43. doi: 10.1016/j.mad.2006.01.011. Epub 2006 Mar 2. Mech Ageing Dev. 2006. PMID: 16513159 Review.
-
Human immunosenescence: does it have an infectious component?Ann N Y Acad Sci. 2006 May;1067:56-65. doi: 10.1196/annals.1354.009. Ann N Y Acad Sci. 2006. PMID: 16803971 Review.
-
Biomarkers of human immunosenescence: impact of Cytomegalovirus infection.Curr Opin Immunol. 2009 Aug;21(4):440-5. doi: 10.1016/j.coi.2009.05.012. Epub 2009 Jun 15. Curr Opin Immunol. 2009. PMID: 19535233 Review.
Cited by
-
Circulating T Cells and Cardiovascular Risk in People With and Without HIV Infection.J Am Coll Cardiol. 2022 Oct 25;80(17):1633-1644. doi: 10.1016/j.jacc.2022.08.756. J Am Coll Cardiol. 2022. PMID: 36265959 Free PMC article.
-
An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturation.J Virol. 2013 Mar;87(6):3062-75. doi: 10.1128/JVI.02510-12. Epub 2013 Jan 2. J Virol. 2013. PMID: 23283945 Free PMC article.
-
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.J Acquir Immune Defic Syndr. 2014 May 1;66(1):25-32. doi: 10.1097/QAI.0000000000000095. J Acquir Immune Defic Syndr. 2014. PMID: 24378728 Free PMC article.
-
Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults.Front Immunol. 2018 May 15;9:1035. doi: 10.3389/fimmu.2018.01035. eCollection 2018. Front Immunol. 2018. PMID: 29868000 Free PMC article. Clinical Trial.
-
Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity.PLoS One. 2017 Jul 6;12(7):e0180691. doi: 10.1371/journal.pone.0180691. eCollection 2017. PLoS One. 2017. PMID: 28683106 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials